ICOSA
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Specialising in patent matters related to life sciences, medtech and AI-driven innovation, ICOSA delivers investor-focused IP strategies for start-ups and scale-ups. Caroline de Mareüil-Villette leads patent valuation and fundraising due diligence, while Claire Verschelde covers biotech prosecution and opposition work. Virgile Grandclaude is a key contact for clients from the chemical industry.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Working with the ICOSA team has been a fantastic experience. The team is highly knowledgeable, approachable and responsive. ICOSA makes complex matters straightforward and stress-free. We see them as a true partner we can rely on, and their support has been invaluable.'
- ‘In my opinion, the main strength of the ICOSA team is their responsiveness and professionalism: quick, high-quality responses delivered with a supportive, non-commercial approach. This demonstrates their genuine interest in science.'